Skip to content
Research Article Open access CC BY 4.0

Nootropic Property of Punica grantum Extract as BDNF4 Stimulant for Treatment of Major Depressive Disorder

Mudassir Alam, Kashif Abbas, Gowhar Ashiq Dar, Nosaiba, Khursheed Ahmed

International Neuropsychiatric Disease Journal · pp. 24–35 · Published 2 Mar 2024

10.9734/indj/2024/v21i2424

Abstract

In 2008, the World Health Organization (WHO) stressed major depressive disorder (MDD) as the third most important cause of disease burden worldwide. Based on their projections, it is expected that by 2030, MDD will take the lead among the rest of the world’s health concerns. Brain derived neurotrophic factor 4 (BDNF4), a protein of neurotrophins family play pivotal role in maintaining neural plasticity, and its reduced level in the hippocampus and plasma have been reported in patients with MDD. Nootropic drugs serve as therapeutic interventions in mitigating MDD through diverse molecular mechanisms. Punica granatum (pomegranate) is acknowledged for its nutritional and medicinal properties, currently under medical scrutiny for its potential as a natural antidepressant. Various computational methodologies, including molecular docking, pharmacokinetics, ADME (absorption, distribution, metabolism and excretion) profile assessment, toxicological analysis, and prediction of biological activity, were employed to identify promising compounds among the phytochemicals present in Punica extract, focusing on their potential BDNF4-stimulating, nootropic, and antidepressant properties. The comprehensive examination of docking scores, interactions between proteins and ligands, pharmacological and toxicological attributes, along with the forecasting of biological activities, collectively underscores the potential attributes of M-Cymene, Flavylium, 2-(4-Methylphenyl)propan-2-ol, Thymol, and Pelletierine as prospective drug candidates targeting human BDNF4 for alleviating MDD.

Antidepressant BDNF4 drug In silico major depressive disorder nootropic

References (26)

  1. 1 AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading [DOI]
  2. 2 SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules [DOI]
  3. 3 Open Babel: An open chemical toolbox [DOI]
  4. 4 Molecular Properties That Influence the Oral Bioavailability of Drug Candidates [DOI]
  5. 5 Small-Molecule Library Screening by Docking with PyRx [DOI]
  6. 6 Major depressive disorder [DOI]
  7. 7 Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model [DOI]
  8. 8 The Role of BDNF on Neural Plasticity in Depression [DOI]
  9. 9 Depression and everyday social activity, belonging, and well-being. [DOI]
  10. 10 Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases [DOI]
  11. 11 Neurotrophins and the immune system [DOI]
  12. 12 TrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders [DOI]
  13. 13 Brain-Derived Neurotrophic Factor (BDNF): Novel Insights into Regulation and Genetic Variation [DOI]
  14. 14 Neurotrophins and Psychiatric Disorders [DOI]
  15. 15 NF-KappaB in Long-Term Memory and Structural Plasticity in the Adult Mammalian Brain [DOI]
  16. 16 Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case–control study with or without antidepressant therapy [DOI]
  17. 17 Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin [DOI]
  18. 18 Neurotrophic factors and their effects in the treatment of multiple sclerosis [DOI]
  19. 19 Fear Extinction as a Model for Synaptic Plasticity in Major Depressive Disorder [DOI]
  20. 20 Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects [DOI]
  21. 21 A red pomegranate fruit extract-based formula ameliorates anxiety/depression-like behaviors via enhancing serotonin (5-HT) synthesis in C57BL/6 male mice [DOI]
  22. 22 Herbal Interventions as Promising Therapeutics for Alleviating of Depression [DOI]
  23. 23 “An Insight into Neurodegenerative Disorders, their therapeutic approaches and drugs available for tackling with Neurodegeneration: A Review” [DOI]
  24. 24 Interaction of Nootropic Drugs with Neurotransmitter Enzyme Acetylcholinesterase: An Insilico Approach: A Review [DOI]
  25. 25 A Review on Intricate Scheme of Therapeutic Approaches Involved in Control and Prevention of Episodic Migraine [DOI]
  26. 26 IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics [DOI]

Cited by 14

Kalyanak Ghrita Mitigates Ethanol Craving in Ethanol-dependent Mice Model

Tanvi M. Chotai, Sarita Mahendra Kapgate · Journal of Ayurveda · 2025

Omega-3 Fatty Acids from Fish: A Novel Approach in Cancer Therapy

Kashif Abbas, Fatima Kamil, Yusra Tanveer · Biosciences Biotechnology Research Asia · 2024

Showing 4 of 14 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

40

Page views

0

PDF downloads

4

Outbound clicks

14

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.